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The positive transcription elongation factor P-TEFb is a pivotal regulator of gene expression in higher cells. Originally
identified in Drosophila, attention was drawn to human P-TEFb by the discovery of its role as an essential cofactor for HIV-1
transcription. It is recruited to HIV transcription complexes by the viral transactivator Tat, and to cellular transcription
complexes by a plethora of transcription factors. P-TEFb activity is negatively regulated by sequestration in a complex with the
HEXIM proteins and 7SK RNA. The mechanism of P-TEFb release from the inhibitory complex is not known. We report that P-
TEFb-dependent transcription from the HIV promoter can be stimulated by the mRNA encoding HIC, the human I-mfa domain-
containing protein. The 39-untranslated region of HIC mRNA is necessary and sufficient for this action. It forms complexes with
P-TEFb and displaces 7SK RNA from the inhibitory complex in cells and cell extracts. A 314-nucleotide sequence near the 39 end
of HIC mRNA has full activity and contains a predicted structure resembling the 39-terminal hairpin of 7SK that is critical for
P-TEFb binding. This represents the first example of a cellular mRNA that can regulate transcription via P-TEFb. Our findings
offer a rationale for 7SK being an RNA transcriptional regulator and suggest a practical means for enhancing gene expression.
Citation: Young TM, Tsai M, Tian B, Mathews MB, Pe’ery T (2007) Cellular mRNA Activates Transcription Elongation by Displacing 7SK RNA. PLoS
ONE 2(10): e1010. doi:10.1371/journal.pone.0001010
INTRODUCTION
The positive transcription elongation factor b (P-TEFb) is a general
transcription elongation factor and a protein kinase that
phosphorylates the carboxy-terminal domain (CTD) of RNA
polymerase II as well as other transcription factors [1,2]. P-TEFb
is composed of CDK9 and either cyclin T1, T2, or K. Cyclin T1
and CDK9 cooperate with the Tat protein and TAR RNA
element of human immunodeficiency virus type 1 (HIV-1) to
ensure processive transcription of the viral genome [3–5].
Numerous cellular proteins interact with P-TEFb [6–19] which
appears to lie at the crossroads of multiple pathways including cell
growth, differentiation, development, stress, apoptosis, and in-
fection [13,20–31]. P-TEFb is present in cells in an active form
associated with the recruiting factor Brd4 [32,33], and in repressed
form associated with the hexamethylene bisacetamide (HMBA)-
induced proteins HEXIM1 or HEXIM2 and 7SK RNA
[9,10,27,28,34,35]. HEXIM1 is an RNA binding protein [36]
and 7SK is an abundant and evolutionary conserved small nuclear
RNA (snRNA). The inhibitory complex, which engages ,50% of
P-TEFb and ,30% of the cellular 7SK, is disassembled under
stress conditions releasing P-TEFb to function in transcription.
The 7SK/HEXIM/P-TEFb regulatory complex is strikingly
reminiscent of the TAR/Tat/P-TEFb complex [37] although it
blocks P-TEFb function. Mechanistically, the binding of 7SK and
HEXIM decreases the kinase activity of P-TEFb and prevents its
recruitment to the HIV-1 promoter. Hence, the 7SK/HEXIM/P-
TEFb interaction may serve as a principal control point for the
induction of cellular and HIV-1 viral gene expression during
stress-related responses [10,20,27,28,38].
It is not known how P-TEFb is released from the inhibitory
RNA-protein complex, but recent reports have identified new
7SK-containing complexes with RNA helicase A (RHA) and
a number of hnRNP proteins [39,40]. The level of 7SK in these
complexes increases concomitantly with the disassembly of the
7SK/HEXIM/P-TEFb complex.
Here we report that RNA from the 39-untranslated region
(3’UTR) of the human I-mfa domain containing protein, HIC, is
present in and regulates P-TEFb complexes. The C-terminus of
HIC contains a cysteine-rich I-mfa domain which is 82 aa long
and 74% identical to the corresponding region of the cellular
protein I-mfa (inhibitor of MyoD family a) [41,42]. We previously
found that the HIC and I-mfa proteins interact with both the
cyclin T1 subunit of P-TEFb and with HIV-1 Tat [12,42]. These
interactions are mediated by the proteins’ homologous I-mfa
domains, which are inhibitory to Tat and P-TEFb transcription.
Paradoxically, however, HIC cDNA activates transcription from
the HIV promoter in a fashion that is dependent on P-TEFb [12].
We analyze this discrepancy and demonstrate that the activation is
mediated by HIC mRNA rather than HIC protein. The 3’UTR of
HIC mRNA binds to and activates P-TEFb by displacing 7SK
RNA from its complex with the elongation factor. This is the first
example of a cellular mRNA that regulates elongation via
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for understanding why this transcription factor is controlled by
RNA molecules including 7SK and TAR. We anticipate that
additional cellular mRNAs will be found to have a role in
transcriptional regulation via P-TEFb.
RESULTS
The 3’UTR of HIC is required to activate gene
expression
The HIC protein interacts with viral and cellular transcription
factors and regulates transcription driven by viral promoters
[12,42,43]. HIC, and the I-mfa protein itself, modulate signal
transduction pathways involved in cell fate, differentiation, and
apoptotic events [44–48]. HIC interacts with P-TEFb by binding
to its cyclin T1 subunit, and it also binds to HIV-1 Tat [12].
Similar results have recently been obtained with the I-mfa protein
[42]. These interactions are all dependent on the I-mfa domain at
the proteins’ C-termini (Fig. 1A).
HIC cDNA (here called HIC(+)), activates Tat-mediated gene
expression from the HIV-1 promoter in its long terminal repeat
(LTR) [12]. Truncations within the HIC I-mfa domain (Fig. 1A)
interacted and co-localized differentially with cyclin T1 and Tat.
Removal of the I-mfa domain in whole (HICD1) or in part
(HICD2 and D3) abrogated the interactions with cyclin T1, but
the smaller I-mfa deletions retained some (HICD2) or all (HICD3)
of their ability to co-immunoprecipitate and co-localize with Tat
[12]. To determine whether the effect of HIC(+) on HIV LTR-
driven gene expression correlates with the interaction of HIC with
cyclin T1 and/or HIV-1 Tat, we tested these truncations in
transient expression assays in 3T3 cells (Fig. 1B). In these cells,
efficient Tat transactivation is dependent on the supply of human
cyclin T1 which binds HIV-1 Tat and TAR better than its
murine ortholog [49]. As seen previously [12], HIC(+) gave a 3–
3.5 fold stimulation of Tat-mediated reporter gene expression in
the presence of cyclin T1 and a ,2 fold enhancement in its
absence (Fig. 1B, gray bars). However, none of the HIC
truncations stimulated HIV LTR-driven gene expression either
in the presence or absence of cyclin T1 (Fig. 1B). These results
appeared to be consistent with a requirement for direct
interaction between the I-mfa domain of HIC and the cyclin
T1 subunit of P-TEFb.
Immunoblot analysis showed that the C-terminally truncated
proteins, which were expressed from constructs lacking the
3’UTR, accumulated to substantially higher levels than full-length
HIC protein expressed from HIC(+) (Fig. 1C; compare lanes 3–5
with lane 1). Removal of most of the 3’UTR from the HIC cDNA,
giving the HIC(2) construct (Fig. 1A), also led to elevated HIC
protein levels (Fig. 1C, lane 2). Thus HIC protein expression is
down-regulated by its 3’UTR, consistent with the presence of
a regulatory element in the 3’UTR. This conclusion is supported
by comparison of the levels of HICD1 protein generated from
plasmids lacking and containing the 3’UTR (Figs. 1C and 3B).
Because the HIC(2) construct expresses the full-length HIC
protein, we expected that like HIC(+) it would activate
transcription from the HIV-1 promoter. Surprisingly, HIC(2)
failed to activate expression of firefly luciferase from the HIV-1
promoter (Fig. 1D). In view of the high level of HIC protein
expression from HIC(2), we entertained the possibility that this
failure might be attributable to an excessive production of HIC
protein by this plasmid. Transfection assays were conducted with
a range of HIC(2) plasmid concentrations, encompassing amounts
that gave rise to levels of HIC protein equal to that derived from
HIC(+). In no case did HIC(2) stimulate expression from the HIV
LTR (Fig. 1E). Similar results were obtained in the simian and
human cells lines COS and HeLa (Fig. 2). These observations
suggest that the 3’UTR of HIC cDNA is necessary for HIC to
activate HIV gene expression.
Sequences in mRNA 3’UTRs that determine the site of
translation of an mRNA can influence the function of the
resultant protein [50], but several experiments argue that such
phenomena do not account for the findings illustrated in Figure 1.
First, the intracellular distribution of HIC generated from the
HIC(2) plasmid was similar to that of HIC from HIC(+), and it
Figure 1. Activation of HIV-1 promoter by HIC cDNA requires its
3’UTR. (A) Schematic representation of HIC RNAs. The boxed area
represents the protein coding region, including the C-terminal I-mfa
domain. Full-length HIC cDNA is referred to as HIC(+). HIC(2) lacks all
but the first 109 nt of the 2,821 nt HIC 3’UTR. (B) NIH 3T3 cells were co-
transfected with the pcDNA3.1-FLAG-HIC vectors specified (2 mg), the
HIV-1 LTR-firefly luciferase (100 ng) and CMV-Renilla luciferase (20 ng)
reporter plasmids, pcDNA3.1-HA-Tat (5 ng) and pcDNA3.1-HA-cyclin T1
(T1; 100 ng) as indicated, and pcDNA3.1 empty vector to maintain
a constant amount of DNA in each sample. Transactivation was
measured at 24 hours post-transfection and expressed as fold Tat
transactivation, calculated as the relative firefly:Renilla luciferase activity
normalized to the value obtained without Tat, cyclin T1 or HIC. Data
represent the average of three experiments with standard errors. (C)
Expression of HIC protein. Extracts of cells (10 mg protein) transfected
with Tat, cyclin T1 and the indicated HIC expression vectors were
analyzed by western blotting using anti-FLAG antibody. (D) Tat
transactivation was measured in the presence of HIC cDNAs carrying
or lacking the 3’UTR. Assays were conducted as in panel B. (E) Reduced
amounts of HIC(2) vector were compared to 2 mg of HIC(+) and
assayed as in panel B. Data represent the average of two experiments.
Inset: HIC protein in cell extracts monitored as in panel C.
doi:10.1371/journal.pone.0001010.g001
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Tat in the nucleolus to the same extent as HIC from the HIC(+)
plasmid (data not shown, [12]). Second, HIC protein interacted
with cyclin T1 (and indirectly with CDK9) and HIV-1 Tat in co-
immunoprecipitation experiments regardless of whether it was
expressed from cDNA containing or lacking the 3’UTR [12,42].
Third, HIC produced in E. coli as a GST fusion protein interacted
with both cyclin T1 and P-TEFb from HeLa cell extracts [12]. We
conclude that the inability of HIC(2) to activate gene expression is
probably not due to a failure of HIC protein to localize correctly
or to interact with P-TEFb or Tat when expressed from a cDNA
lacking the 3’UTR.
The HIC 3’UTR is sufficient to activate gene
expression
To evaluate the contribution of the HIC protein coding sequence
to the HIC 3’UTR-dependent activation of gene expression, we
tested two further pairs of plasmids expressing different parts of the
protein from vectors that either contain or lack the HIC 3’UTR
(Fig. 3A). As a partner to HICD1 which lacks both the I-mfa
domain and 3’UTR, we generated HICD1(+). This plasmid is
identical to HIC(+) except that it has a point mutation which
introduces a stop codon at amino acid 164, immediately before the
I-mfa domain. We also deleted the N-terminal half of the HIC
protein coding sequence, yielding HIC C-terminal constructs that
possess or lack the 3’UTR (HIC-Cter(+) and HIC-Cter(2)).
These vectors stimulated expression from the HIV promoter
only if they contained the HIC 3’UTR, irrespective of the nature
of the proteins encoded (Fig. 3A). Remarkably, the I-mfa domain,
which interacts with cyclin T1 and Tat, was not required as shown
by comparing the activity of the vectors HIC-Cter(2) and HIC-
Figure 2. The 3’UTR of HIC is Necessary to Activate Tat Transactiva-
tion in HeLa and COS cells. (A) COS cells were co-transfected with the
pcDNA3.1-FLAG-HIC vectors specified, the HIV-1 LTR-firefly luciferase
(100 ng) and RSV-Renilla luciferase (100 ng) reporter plasmids,
pcDNA3.1-HA-Tat (5 ng) and pcDNA3.1 empty vector to maintain
a constant amount of DNA in each sample. Reduced amounts of HIC(2)
vector were compared to 2 mg of HIC(+). Transactivation was measured
at 24 hours post-transfection and expressed as fold Tat transactivation,
calculated as the relative firefly:Renilla luciferase activity normalized to
the value obtained without Tat and HIC. Data represent the average of
two experiments. Inset: HIC protein in cell extracts monitored by
western blotting using anti-FLAG antibody. (B) HeLa cells were co-
transfected with pcDNA3.1-FLAG-HIC vectors specified, HIV-1 LTR-firefly
luciferase (100 ng), CMV-Renilla luciferase (20 ng) reporter plasmids,
pcDNA3.1-HA-Tat (5 ng) and pcDNA3.1 empty vector to maintain
a constant amount of DNA in each sample. Reduced amounts of HIC(2)
vector were compared to 2 mg of HIC(+). Transactivation was measured
at 24 hours post-transfection and expressed as fold Tat transactivation,
calculated as the relative firefly:Renilla luciferase activity normalized to
the value obtained without Tat and HIC. Data represent the average of
two experiments. Inset: HIC protein in cell extracts monitored by
western blotting using anti-FLAG antibody.
doi:10.1371/journal.pone.0001010.g002
Figure 3. The HIC 3’UTR fragments are sufficient to increase gene
expression. (A) NIH 3T3 cells were transfected with the pcDNA3.1-FLAG
vectors indicated, together with other plasmids as in Fig. 1B. The
pcDNA3.1-FLAG vectors expressed regions of the HIC protein and cDNA
shown. Note that the HICD1(+) construct is identical to HIC(+) except for
a point mutation that truncates the protein immediately before its I-mfa
domain. Data represent the average of three experiments with standard
errors and are presented as in Fig. 1B. (B) HIC protein expression was
monitored as in Fig. 1C. (C) Deletions expressing the indicated regions
of the 3’UTR were assayed as in panel A. Asterisks (*) indicate that the
activities of the two shortest fragments were statistically different from
the full-length 3’UTR (P=0.0188 and 0.0181, respectively, in a Student’s
t-Test (two-tailed distribution, two-sample unequal variance)). (D) Total
RNA was analyzed by relative quantitative RT-PCR using primers against
the 39 end of the HIC 3’UTR, and b-actin mRNA as an internal standard,
producing fragments of 101 and 294 bp, respectively.
doi:10.1371/journal.pone.0001010.g003
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whether the protein coding region is entirely dispensable for this
activity, by testing a vector that expresses the 3’UTR alone. As seen
in Figure 3A, this construct activated Tat- and cyclin T1-mediated
reporter gene expression by ,3 fold, just as well as HIC(+). The
3’UTR did not activate expression in the absence of Tat and human
cyclin T1 (Fig. 3A), thereby excluding general effects on expression
from the HIV LTR. We deduce that the 3’UTR of HIC is sufficient
aswell asnecessaryforthe Tat-and cyclinT1-mediatedactivation of
gene expression from the HIV-1 LTR.
The HIC 3’UTR is long, ,2.8 kb, compared to a mean of
,1.0 kb for human mRNAs [51]. To address the minimal
fragment size that retains activity, we generated a nested set of
truncations containing the 39 end of the 3’UTR (Fig. 3C). A
3’UTR fragment 1623 nucleotides (nt) in length gave a ,3 fold
activation, similar to that elicited by HIC(+) cDNA or its almost
full-length 3’UTR (2,712 nt). Truncations producing fragments of
863 and 314 nt, gave an activation of ,2.5 fold, which was not
statistically different from that of the full-length 3’UTR. Fragments
of 212 and 177 nt elicited a lesser stimulation, ,1.75 fold (Fig. 3C).
Analysis by semi-quantitative reverse transcription followed by
polymerase chain reaction (RT-PCR) demonstrated that RNA was
produced from each truncation at roughly the same levels
(Fig. 3D). These data show that specific short fragments of the
3’UTR can activate gene expression.
The 3’UTR of HIC activates transcription from the
HIV LTR
RNase protection assays were carried out to ascertain whether
stimulation of gene expression by the HIC 3’UTR reflects an
action at the RNA level. As expected, Tat (in the presence of
human T1) increased the abundance of luciferase transcripts from
the HIV LTR-firefly luciferase construct, whereas transcripts from
the control vector (CMV-Renilla luciferase) were unaffected
(Fig. 4A, left). A further increase in firefly, but not Renilla,
luciferase transcripts was elicited by HIC(+) but HIC(2) had little
or no effect. The HIC 3’UTR alone was sufficient to increase
firefly luciferase RNA (Fig. 4A, right). RT-PCR analysis
demonstrated that comparable amounts of 3’UTR RNA were
produced from the HIC(+) and HIC 3’UTR plasmids (Fig. 4A,
bottom right). In other experiments, the 314 nt 39-terminal
fragment of the 3’UTR also increased the level of firefly luciferase
transcripts (data not shown). Thus, the HIC 3’UTR is both
necessary and sufficient to increase firefly luciferase reporter RNA
levels driven by the HIV-1 LTR. Similar results were obtained in
HeLa and COS cells (data not shown).
Next we tested the effect of HIC(+) on a different reporter
driven by the HIV-1 LTR. In 3T3 cells, expression of the
chloramphenicol acetyltransferase (CAT) from the HIV LTR was
also enhanced ,3 fold by HIC(+) (Fig. 4B) while expression of
firefly luciferase from the PCNA promoter, which is only weakly
dependent on P-TEFb [11], was only mildly stimulated by HIC(+)
(Fig. 4C) or the HIC 3’UTR alone (data not shown). These results
argue against effects on protein or mRNA stability and strongly
suggested that the 3’UTR functions at the level of transcription.
Tat is an RNA-binding transcriptional activator that functions by
recruiting P-TEFb to the HIV promoter [52]. To determine
whether this viral protein is required for activation of gene
expression by the HIC 3’UTR, we took advantage of a modified
HIV promoter that can bind cyclin T1 in the absence of Tat. The
HIV-1 LTR-firefly luciferase construct is furnished with Gal4
binding sites upstream of the viral promoter. When co-transfected
with a vector encoding a Gal4 binding domain (Gal4BD)-cyclin
T1 fusion protein, P-TEFb is artificially tethered to the HIV-1
LTR [53]. In this system, expression from the HIV-1 LTR was
stimulated ,2 fold by HIC(+) or by the isolated HIC 3’UTR but
not by HIC(2) (Fig. 4D). These data implicated P-TEFb in the
response of the HIV-1 promoter to the HIC 3’UTR.
The 3’UTR of HIC binds P-TEFb and displaces 7SK
RNA
P-TEFb complexes of two types have been identified: inactive
complexes contain HEXIM proteins and 7SK RNA, both of which
are absent from active complexes. The release of 7SK RNA,
resulting in the activation of P-TEFb, has been observed as
a response to stress [20,27,28]. We therefore considered the
possibility that the HIC 3’UTR may activate gene expression by
displacing 7SK RNA. First, to determine whether HIC 3’UTR
functions through the P-TEFb/7SK/HEXIM mechanism, we
examined the effect of HEXIM1 on the response to the HIC
3’UTR (Fig. 5A). Overexpression of HEXIM1 caused a small
inhibition of Tat-dependent gene expression, presumably by
decreasing the availability of active P-TEFb [34,54–56], but almost
completely suppressed the ability of the 3’UTR to enhance Tat
transactivation (Fig. 5A). The observation that the effect of the HIC
3’UTR is antagonized by HEXIM1 suggested that it targets the
samecomplex. To test this hypothesis, we next investigated the effect
of HIC 3’UTR on the binding of 7SK RNA to P-TEFb. P-TEFb
wasimmunoprecipitated withanti-CDK9antibodyand analyzedfor
its 7SK RNA content by RT-PCR after transfection of HIC(+)o r
HIC 3’UTR which activate transcription, or HIC(2) that has no
effectontranscription (Fig. 5B). Transfection of HIC(+)o ri t s3 ’ U T R
reduced the amount of 7SK RNA immunoprecipitated with P-
TEFb, whereas HIC(2) did not (Fig. 5B, left). Semi-quantitative
analysis indicated that the transfected HIC 3’UTR caused a 20–30
fold reduction of P-TEFb-associated 7SK (Fig. 5B, right). As
additional controls, we tested the 3’UTRs of cardiac actin,
tropomyosin and troponin (AC, TM, and TP), all of which failed
to stimulate luciferase expression from the HIV-1 LTR in
transactivation assays (Fig. 5C). Expression of the 3’UTRs was
verified by RT-PCR (data not shown). Immunoprecipitated P-TEFb
from these transfections contained approximately equal amounts of
CDK9 (Fig. 5D), but only the HIC 3’UTR displaced 7SK RNA
from the complex (Fig. 5E).
If the HIC 3’UTR replaces 7SK RNA in P-TEFb complexes,
we would expect to find the HIC 3’UTR in such complexes.
Analysis of anti-CDK9 immunoprecipitates by RT-PCR showed
that HIC RNA was present in P-TEFb complexes from cells
transfected with empty vector, and at much higher levels
(.10,000-fold more) in complexes from cells overexpressing the
3’UTR (Fig. 6A). The 3’UTR was present in P-TEFb immuno-
precipitates from untransfected cells but was not detected when
immunoprecipitation was conducted with an irrelevant antibody
(anti-HA; Fig. 6B). Estimation of P-TEFb–associated RNAs
indicated that in transfected cells the 3’UTR was present at a level
slightly higher than 7SK RNA in control cells. In further
experiments the HIC coding region was also detected (data not
shown). Thus, both endogenous and exogenous HIC mRNA is
associated with P-TEFb in cells.
Finally, we sought direct evidence that the HIC 3’UTR can
displace 7SK RNA from P-TEFb complexes. The HIC 3’UTR,
synthesized in vitro using T7 RNA polymerase, was incubated
with nuclear extract from HeLa cells and P-TEFb immunopre-
cipitates were examined for 7SK RNA. As in transfected cells, the
HIC 3’UTR displaced 7SK RNA from the P-TEFb complexes
whereas a control RNA (AC 3’UTR) synthesized in the same way
3’UTR Activates Transcription
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conclusion that the HIC 3’UTR activates gene expression by
displacing 7SK from repressed P-TEFb complexes.
DISCUSSION
Multiple functions have been found to reside in mRNA 3’UTRs,
including elements governing RNA stability, localization and
translation. Our work shows that the unusually long HIC 3’UTR
harbors a novel function which stimulates transcription via P-TEFb
by displacing 7SK. This finding reconciles the observations that
transfected HIC cDNA stimulates P-TEFb–dependent gene expres-
sion whereas the HIC and I-mfa proteins are inhibitory in a cell-type
dependent manner [12,42]. More importantly, it suggests a mech-
anism for release of P-TEFb from inhibitory complexes. For
example, in stress-induced cardiac hypertrophy or after exposure
to UV radiation or transcription inhibitors, increased P-TEFb
activity correlates with decreased 7SK RNA binding [20]. The
mechanisms whereby these stress signals reach the 7SK-containing
P-TEFb complex are not known. Our observations raise the
possibility that RNA sequences in mRNAs or in other RNA
molecules, function like the HIC 3’UTR to activate P-TEFb.
A predicted structural element in HIC 3’UTR
7SK serves as a structural scaffold for HEXIM1 and P-TEFb in
the inhibitory complex, as well as for the binding of other proteins.
Recent investigations have revealed a high degree of specificity in
the interaction of cellular proteins with structural elements of 7SK.
For example, the single-stranded RNA binding proteins
Figure 4. The HIC 3’UTR acts at the transcriptional level. (A) NIH 3T3 cells were co-transfected with the two firefly luciferase reporter plasmids, and
vectors expressing Tat, cyclin T1 and the indicated HIC vectors as in Fig. 1B. RNA was isolated from nuclear fractions 24 hours post-transfection,
subjected to RNase protection assays [12] and hybridized to probes for firefly luciferase RNA (top), or Renilla luciferase RNA to control for transfection
efficiency (bottom). The control lacked cellular RNA but was digested with RNases A and T1. The probe lane contains 10% of the input probe RNA.
Arrows indicate the position of protected luciferase probes. Bar graphs represent data averaged from two experiments calculated as relative
firefly:Renilla RNA levels normalized to the sample with cyclin T1 but not Tat or HIC. Relative quantitative RT-PCR was performed as in Fig. 3D to
examine HIC 3’UTR and b-actin mRNA levels. (B) HIC Activates Tat-mediated CAT expression. NIH 3T3 cells were co-transfected with the reporter
plasmids HIV-1-CAT (100 ng) and CMV-Renilla luciferase (20 ng), and the plasmids pcDNA3.1-HA-Tat (5 ng), pcDNA3.1-HA-cyclin T1 (T1) (100 ng),
2 mg pcDNA3.1-HIC(+) expression vector, or pcDNA3.1 empty vector as indicated. Transactivation was measured at 24 hours post-transfection and
expressed as fold Tat transactivation, calculated as the relative CAT:Renilla luciferase activity normalized to the value obtained without Tat, cyclin T1
and HIC. Data represent the average of three experiments with standard errors. (C) The PCNA promoter is only slightly responsive to HIC(+). NIH 3T3
cells were co-transfected with100 ng HIV-1 LTR-firefly luciferase (light bars) or PCNA-firefly luciferase (dark bars) and other vectors as in Fig. 1B. (D) Tat
is dispensable in the tethering system. NIH 3T3 cells were co-transfected with Gal4BD-HIV-1 LTR-firefly luciferase reporter plasmid and Gal4BD-T1
expression vector (100 ng each), 20 ng CMV-Renilla luciferase reporter plasmid, 5 ng pcDNA3.1-HA-Tat expression vector, and 2 mg pcDNA3.1 vectors
expressing FLAG-HIC(+), FLAG-HIC(2) or the HIC 3’UTR alone as indicated. Data represent the average of three experiments with standard errors,
presented as fold activation by Gal4BD-T1 at 24 hours calculated as the relative firefly:Renilla luciferase activity normalized to the value obtained
without Gal4BD-T1, HIC or Tat. The schematic diagrams the HIV-1 LTR-firefly luciferase construct furnished with five upstream Gal4 sites, and the
Gal4BD-cyclin T1 fusion protein (Gal4BD-T1).
doi:10.1371/journal.pone.0001010.g004
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R and Q1 bind stems 1 and 3 [40]. Stem 1 is also important for the
binding of RHA [40]. An extensive structure-function study led to
the demonstration that both the 59- and 39-terminal stem-loop
structures of 7SK are required for binding P-TEFb in vivo. The 59
stem-loop structure (stem 1) is necessary for binding HEXIM1,
which is a prerequisite for binding P-TEFb; in the next step, the
39-terminal hairpin of 7SK (stem 4; [57]) interacts with P-TEFb
[37]. We therefore used bioinformatic tools to examine the
terminal segment of the HIC 3’UTR for the existence of an
imperfect stem-loop structure that resembles stem 4 of 7SK [57].
A similar hairpin structure is predicted within the HIC 3’UTR (nt
4002–4030; Fig. 7, shaded area 1). The loop region of this hairpin
contains a sequence, AUPuUGG, that is shared with stem 4 of
7SK RNA (Fig. 7, inset). A neighboring sequence in the HIC
3’UTR (nt 4048–4108 shaded area 2) is predicted to form
Figure 5. The HIC 3’UTR releases 7SK RNA from P-TEFb complexes. (A)
HEXIM1 antagonizes activation by the HIC 3’UTR. HeLa cells were co-
transfected in the presence or absence of pFLAG-CMV2-HEXIM1 (2 mg).
Other plasmids and experimental details were as in Fig. 1B. Data
represent the average of five experiments with standard errors. (B) HIC
3’UTR is sufficient to release 7SK from P-TEFb. HeLa cells were
transfected with 100 ng HIV-1 LTR firefly luciferase and 20 ng CMV
Renilla luciferase, with or without 5 ng HIV-1 Tat and 2 mg pcDNA3.1
empty vector, HIC(+), HIC(2) or the 3’UTR alone as indicated. Cells were
harvested 24 hours post-transfection and assayed for firefly and Renilla
luciferase activity to verify activation by HIC(+) and the 3’UTR (data not
shown). P-TEFb was immunoprecipitated from cell extracts using
antibody against CDK9. RNA was extracted from immunoprecipitates
and subjected to RT-PCR using primers against 7SK RNA. The number of
PCR cycles is specified for each experiment. (C) The 3’UTR of HIC
specifically activates gene expression. HeLa cells were transfected as in
panel A, and with 2 mg of vectors expressing the 3’UTR of cardiac actin
(AC), tropomyosin (TM), or troponin (TP) as controls. Cells were
harvested 24 hours post-transfection and assayed for firefly and Renilla
r
luciferase activity. Data are represented as firefly/Renilla activity
normalized to the sample without Tat. (D) Cell extracts were
immunoblotted and probed with antibody to CDK9. (E) HIC 3’UTR
specifically releases 7SK RNA from P-TEFb. Immunoprecipitated P-TEFb
was assayed for 7SK RNA as in panel B. The number of PCR cycles is
specified.
doi:10.1371/journal.pone.0001010.g005
Figure 6. The HIC 3’UTR binds to P-TEFb. (A) Endogenous HIC 3’UTR
binds to P-TEFb and overexpression of the 3’UTR results in an increased
amount of HIC 3’UTR RNA bound to P-TEFb. HeLa cells were transfected
with 2 mg of empty vector or HIC 3’UTR. RNA from immunoprecipitated
P-TEFb was assayed by RT-PCR using primers for the 39 end of the HIC
3’UTR as in Fig. 3D. (B) Endogenous HIC 3’UTR binds P-TEFb. P-TEFb was
immunoprecipitated from HeLa cells using antibody against CDK9.
Antibody against HA was used as a negative control (upper panel).
Immunoprecipitates were examined for HIC RNA as in panel A. (C)
Displacement of 7SK in vitro. HeLa cell nuclear extract [27] was
incubated in the presence of the indicated amounts of in vitro
transcribed HIC 3’UTR or cardiac actin (AC) 3’UTR. P-TEFb was
immunoprecipitated using antibody against CDK9, RNA was extracted
from the immunoprecipitates and subjected to RT-PCR using primers
against 7SK RNA.
doi:10.1371/journal.pone.0001010.g006
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contributes to, but is not essential for, its binding to P-TEFb
[37,57]. Both structures are present in the 314-nt fragment which
retains full activity in stimulating HIV gene expression. They are
also present in the shorter fragments of 212 and 177 nt, which
display partial activity (Fig. 3C), suggesting that additional
sequences contribute to the 3’UTR’s activity. No similar structure
was predicted for the AC 3’UTR which did not displace 7SK in
vivo or in vitro. Such structures present in the 3’UTRs of other
mRNAs may exert the same function. Future structure-function
analysis of the 314-nt fragment will define the RNA elements that
are necessary for HIC 3’UTR function.
Multiple complexes balance the function of P-TEFb
The P-TEFb inhibitory complex has been studied in detail. It was
established that the binding of HEXIM1 to 7SK RNA is required
for its inactivating interaction with P-TEFb. Only about 20% of
HEXIM1 is bound to 7SK [35], and it has recently been shown
that most of HEXIM1 is complexed with unidentified cellular
RNAs in vivo [36]. Similarly, 7SK was recently reported to reside
in a variety of RNA-protein complexes (RNPs) containing for
example hnRNPs [39,40]. Based on our observation that P-TEFb
interacts with elements in the HIC 3’UTR, we consider it likely
that multiple P-TEFb–containing RNPs exist. Microarray analysis
could be used to define the set of mRNAs and non-coding RNAs
that are associated with P-TEFb. We speculate that the interaction
of this transcription factor with mRNAs, or their precursors, is an
evolutionarily ancient aspect of transcriptional control. Further-
more, we speculate that different sets of RNA ligands could be
present under various physiological conditions and states of
differentiation, conferring the ability to fine-tune the regulation
of this essential transcription factor. P-TEFb binds RNA poly-
merase II and phosphorylates the CTD which is involved in many
aspects of transcription and RNA metabolism [58]. P-TEFb itself
is involved in transcription initiation, capping, splicing and 39 end
formation in mammalian, insect and yeast systems [19,59–66] and
increasing numbers of cellular proteins are found to interact with
P-TEFb [67]. Thus, P-TEFb–containing RNPs could have a role
in various aspects of RNA processing as well as in transcription
itself.
HIC protein and mRNA
We initially isolated HIC as a protein that binds the cyclin T1
component of P-TEFb. Subsequently, we found that over-
expression of its I-mfa domain inhibits P-TEFb-dependent gene
expression. In addition, HIC possesses RNA binding activity via
its conserved basic region [42] (Q. Wang, et al. unpublished
results). It is tempting to speculate that the HIC protein and the
3’UTR of its mRNA interact with P-TEFb in a fashion
reminiscent of the Tat/TAR/P-TEFb and HEXIM/7SK/P-
TEFb interactions. In these well-studied instances, RNA molecules
are key participants in the positive and negative regulation of P-
TEFb function, respectively. Interestingly Tat was recently
demonstrated to bind 7SK and disrupt the inhibitory P-TEFb
complex [56,68]. It remains to be determined whether HIC can
also bind to 7SK and disrupt its interaction with HEXIM, thereby
releasing P-TEFb. While the physiological roles of HIC are not yet
well understood, its expression, like that of its Xenopus ortholog
XIC, appears to be under tight control [42,48] (Q. Wang et al.,
unpublished results). The HIC and XIC proteins, which are active
during differentiation and developmental scenarios, could activate
P-TEFb via interactions with cyclin T1 and the HIC 3’UTR
causing a reduction of the inhibitory complex [69,70]. Conceiv-
ably this action could be restricted to the vicinity of the
transcription apparatus at specific genes. Documentation of the
existence of such complexes is an important next step in evaluating
this model.
Finally, our findings suggest a general mechanism whereby gene
expression can be controlled at the level of P-TEFb by signals
transmitted through mRNA as well as protein modulators.
Exploitation of this phenomenon to increase transcription and
gene expression by transfection of the HIC 3’UTR, or its
derivatives, could be useful when enhanced yields of RNA or
protein is required either in commercial or laboratory settings.
MATERIALS AND METHODS
Plasmids and Plasmid Construction
A plasmid containing the 3’UTR of HIC was generated by sub-
cloning the HpaI/XhoI fragment of HIC(+) into pcDNA3.1. All
HIC constructs and additional plasmids for expression in
mammalian cells were generated or obtained as previously
described [12].
Cell Culture
NIH 3T3, COS7 and HeLa cells were obtained from American
Type Culture Collection and maintained in Dulbecco’s Modified
Eagle’s Medium (Invitrogen Corp., Carslbad, CA) supplemented
with 10% heat inactivated fetal bovine serum.
Gene Expression Assays
NIH 3T3 (1610
5 cells), COS (1.6610
5 cells) and HeLa cells
(1.6610
5) were seeded in 6-well dishes and transfected 24 hr later
using Lipofectamine 2000 (Invitrogen). Cells were harvested 24 hr
post-transfection and lysed in 300 ml of passive lysis buffer
according to the manufacturer’s instructions (Promega Corp.,
Madison, WI) for luciferase assays. Lysates were clarified by
centrifugation and assayed for luciferase activity using the
Promega dual luciferase reporter system according to the
manufacturer’s instructions.
Figure 7. Similarity in RNA structure between the 39 terminal region
of HIC mRNA and regions in 7SK RNA. The 314 nt 39 terminal region of
the HIC 39 UTR (nt 3,839–4,152) was aligned with the human 331 nt 7SK
sequence using Foldalign. Two regions of HIC with significant score are
shaded in gray. Region 1 was predicted to be structurally similar to stem
4 of 7SK (boxed) and region 2 to an alternative form of 7SK stem 2.
doi:10.1371/journal.pone.0001010.g007
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NIH 3T3 or HeLa cells were seeded, transfected and harvested for
gene expression assays. Cell extracts (10 mg protein) were
separated by denaturing polyacrylamide gel electrophoresis and
subjected to western blotting as described [71]. Western blots were
probed for FLAG-HIC using anti-FLAG antibody (Sigma-Aldrich,
St. Louis, MO) or for CDK9 using anti-CDK9 antibody (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA).
Relative Quantitative Reverse Transcription-
Polymerase Chain Reaction (RT-PCR)
Total RNA was purified from NIH 3T3 cells, using Trizol
(Invitrogen) according to the manufacturer’s protocol. Total RNA
(2 mg) was subjected to relative quantitative RT-PCR performed
using Quantum RNA b-actin internal standards coupled with RT-
PCR (Ambion). Primers used (sequence available from the authors
upon request) amplify a 101 bp region in the 39 end of the 3’UTR.
PCR products were separated in a 1% agarose gel and stained
with SYBR Green (Molecular Probes, Inc., Eugene, OR). P-
TEFb-associated RNA levels were compared using an amplifica-
tion efficiency value of 70%.
Immunoprecipitation and RNA Isolation
HeLa cells were seeded at 1.6610
5 cells per well in a 6-well dish
and transfected 24 hr later using Lipofectamine 2000 (Invitrogen).
Cells were harvested 24 hr post-transfection in a high salt buffer
containing 25 mM Tris pH 8.0, 250 mM NaCl, 1mM EDTA, 1%
NP40, 0.5 mM PMSF, 0.5 mM DTT and 40 U RNasin. Extracts
were homogenized through a narrow gauge syringe, incubated for
10 min on ice and clarified by centrifugation at 13,0006g for
10 min at 4uC. Immunoprecipitation was performed with protein
A-Sepharose beads and 2 ml rabbit anti-CDK9 antibody (Santa
Cruz Biotechnology Inc., Santa Cruz, CA) for 2 hr at 4uC.
Immunoprecipitates were washed 3 times in high salt buffer, and
beads were heated to 100uC in a buffer containing 25 mM Tris
pH 7.6, 250 mM NaCl, 0.5% SDS and 5 mM EDTA for 5 min.
Half of the mixture was heated with 66Laemmli sample buffer,
resolved in an SDS-polyacrylamide gel, transferred to nitrocellu-
lose and probed with antibody to CDK9. The remaining beads
were pelleted and RNA was isolated from the supernatant using
Trizol (Invitrogen), according to the manufacturer’s instructions.
RT-PCR was performed using the Retroscript kit (Ambion) with
primers directed toward the 3’UTR as above and toward 7SK
RNA which amplify the entire 331 bp of 7SK RNA [20].
RNA Structure Prediction
7SK (NR_001445) and HIC (NM_199072) 3’UTR sequences
were acquired from NCBI. The 314 nt HIC sequence, nt 3,806–
4,152, was divided into 4 overlapping segments of 150 nt each at
75 nt intervals. Each segment was aligned against 7SK using the
RNA structure alignment tool Foldalign [72] with the maximum
motif length set to 100 and default sequence length difference
settings. Foldalign was also used to derive a structure for the
314 nt segment based on its alignments with 7SK RNA.
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